With the increasing need for emergency medical services (EMS), the global market for portable CPR market is witnessing a significant surge in its size and valuation. The rise in the awareness of people pertaining to cardiac arrest and the clinical advantages of the CPR devices, augmenting support of the governments in terms of funds and grants, and the surge in the geriatric population are also propelling this market considerably.
Going forward, the escalating prevalence of cardiovascular diseases and the increasing instances of out-of-hospital cardiac arrest around the world are anticipated to drive the worldwide market for automated CPR devices in the years to come. On the other hand, the high cost associated with automated CPR devices, their weight, the need for extensive training to be able to utilize them, and conflicting outcomes are projected to hamper the growth of this market in the near future.
Request Brochure of Portable CPR Market Report
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26675
Nonetheless, the technological advancements, together with the increasing awareness among people regarding the benefits of cardiac arrest management in emerging regions, such as Latin America and Asia Pacific, are expected to boost the demand for automated CPR devices over the next few years, which is further anticipated to offer lucrative opportunities for global and regional participants in the coming years.
Cardiopulmonary resuscitation (CPR) is an emergency technique used during a heart attack, or drowning condition, when the person is unable to breath. During a cardiac arrest, due to insufficient supply of blood to maintain life, the heart stops beating. In such conditions, blood circulation vital to sustain life can be provided by constantly compressing the heart through a physical force being applied to the patient’s chest. This technique of rescue is termed as cardiopulmonary resuscitation (CPR), which is employed in emergency situations or conditions to protect the patient from fatal myocardial infarction or brain damage.
